US2011217759A1PendingUtilityA1

Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids

Assignee: DE SIMONE CLAUDIOPriority: Mar 11, 1996Filed: May 20, 2011Published: Sep 8, 2011
Est. expiryMar 11, 2016(expired)· nominal 20-yr term from priority
A61K 35/747A61K 31/575A61P 1/16A61P 1/00A61K 31/7016A61K 35/74C12N 1/20C12R 2001/46C12R 2001/225A61K 35/744C12N 1/205
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Strains of bacteria characterized by exhibiting: (a) a 7α-dehydroxylase activity of less than 50%, and (b) a bile acid deconjugation activity of less than 50%, and descendants, mutants and derivatives thereof preserving activities (a) and (b); and a pharmaceutical composition using one or more of such strains and use of same for preventing and treating diseases associated with or caused by an altered metabolism of bile acids.

Claims

exact text as granted — not AI-modified
1 . A bacteria strain characterized by exhibiting: (a) a 7a-dehydroxylase activity of less than 50%, and (b) a bile acid deconjugation activity of less than 50%, and descendants, mutants and derivatives thereof preserving activities (a) and (b). 
     
     
         2 . The strain of  claim 1 , which is a gram-positive bacteria strain. 
     
     
         3 . The strain of  claim 1 , belonging to a species selected from  Streptococcus thermophilus, Streptococcus faecium,  and  Lactobacillus bulgaricus.    
     
     
         4 . The strain of  claim 3 , wherein the bacteria strain is  Streptococcus thermophilus  YS 52 deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1670. 
     
     
         5 . The strain of  claim 3 , wherein the bacteria strain is  Streptococcus thermophilus  YS 46, deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1668. 
     
     
         6 . The strain of  claim 3 , wherein the bacteria strain is  Streptococcus thermophilus  YS 48, deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1669. 
     
     
         7 . The strain of  claim 3 , wherein the bacteria strain is  Streptococcus faecium  SF 3, deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1671. 
     
     
         8 . The strain of  claim 3 , wherein the bacteria strain is  Lactobacillus bulgaricus  LB I deposited with the CNCM, Collection Nationale de Cultures de microorganismes, Institut Pasteur, under the accession number 1-1664. 
     
     
         9 . The strain of  claim 3 , wherein the bacteria strain is  Lactobacillus bulgaricus  LB 3 deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1665. 
     
     
         10 . The strain of  claim 3 , wherein the bacteria strain is  Lactobacillus bulgaricus  LB 7 deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1666. 
     
     
         11 . The strain of  claim 3 , wherein the bacteria strain is  Lactobacillus bulgaricus  LB 77 deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1667. 
     
     
         12 - 36 . (canceled)

Join the waitlist — get patent alerts

Track US2011217759A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.